Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again

By DENISE GRADY from NYT Health https://ift.tt/2UfjXIc
via IFTTT
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again - By DENISE GRADY - at Health - Keyword: Stem Cells, Regulation and Deregulation of Industry - From The New York Times - Published at April 3, 2019 at 07:00AM